Etifoxine

This classification denotes an anxiolytic with the molecular formula C17H17ClN2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier X24X82MX4X, chemically known as 6-chloro-2-ethylamino-4-methyl-4-phenyl-4h-3,1-benzoxazine but more generally known as etifoxine, which bears U.S. National Institutes of Health Compound Identifier 30768. European Medicines Agency schedules Etifoxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07302MIG. The term ETIFOXINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules etifoxine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. ETIFOXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.